E
Power Law company profile
Exscientia
Biotech & Life Sciences · Oxford, United Kingdom · Founded 2012 · IPO 2021 Unicorn
Global footprint
Where Exscientia has talent and traffic
AI talent share
17.6%
of workforce is AI talent
(9 of 51 staff)
(9 of 51 staff)
Core AI59.8%
Other AI47.84%
Non-AI workforce4282.35%
Web traffic by country
490
monthly visits
across markets
across markets
🇯🇵 Japan81.6%
🇺🇸 United States0%
Patent intelligence
$8M patent portfolio · 19 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$8M
1.2% of valuation · 2.5× smaller than top peer Oxford Biomedica ($20M)
19 active patent families
Where Exscientia innovates
Chemical compoundBiological organismMedicinal chemistryMolecular biologyCancer research
Above peer median on Strategic, Market
Quality vs same-sector peers
Exscientia on the five Patsnap quality dimensions
Exscientia in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Exscientia concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Exscientia and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Exscientia on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.